Zydus Mounts Challenge To Novartis With Generic Nelarabine Injection

US Rival To Arranon Has Been Granted 180 Days Of CGT Exclusivity

 
• By Chloe Kent
US Flag Graph
Zydus is building up its US injectables business • Source: Alamy

More from Products

More from Generics Bulletin